These data suggested that CD8+PD1+ T cells lacked immune-surveillance and had tissue-damaging functions27, which were increased by anti-PD1 treatment, possibly contributing to the unfavourable effects of anti-PD1 treatment on HCC development in NASH. The gene discussed is PDCD1; the disease is metabolic dysfunction-associated steatohepatitis.